---
title: "Bank of America Securities Keeps Their Sell Rating on TG Therapeutics (TGTX)"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/291920606.md"
description: "Bank of America Securities analyst Alec Stranahan reiterated a Sell rating on TG Therapeutics (TGTX) with a $20 price target. This contrasts with the broader market consensus, which suggests a Moderate Buy rating and an average price target of $53.17 for the healthcare stock."
datetime: "2026-07-07T10:55:53.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/291920606.md)
  - [en](https://longbridge.com/en/news/291920606.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/291920606.md)
generator: "portal-rs"
---

# Bank of America Securities Keeps Their Sell Rating on TG Therapeutics (TGTX)

Bank of America Securities analyst Alec Stranahan reiterated a Sell rating on TG Therapeutics today and set a price target of $20.00.

### 4th of July Sale - 70% Off

-   Unlock powerful investing tools and data-driven insights with TipRanks Premium for more confident investment decisions.
-   Discover top stock picks and new investment opportunities through TipRanks' Smart Investor Newsletter.

According to TipRanks, Stranahan is a 4-star analyst with an average return of 9.5% and a 53.26% success rate. Stranahan covers the Healthcare sector, focusing on stocks such as Moderna, Agios Pharma, and Revolution Medicines.

The word on The Street in general, suggests a Moderate Buy analyst consensus rating for TG Therapeutics with a $53.17 average price target.

### Related Stocks

- [TGTX.US](https://longbridge.com/en/quote/TGTX.US.md)
- [BAC.US](https://longbridge.com/en/quote/BAC.US.md)
- [MRNA.US](https://longbridge.com/en/quote/MRNA.US.md)
- [AGIO.US](https://longbridge.com/en/quote/AGIO.US.md)
- [RVMD.US](https://longbridge.com/en/quote/RVMD.US.md)
- [BAC-Q.US](https://longbridge.com/en/quote/BAC-Q.US.md)
- [BML-L.US](https://longbridge.com/en/quote/BML-L.US.md)
- [BAC-L.US](https://longbridge.com/en/quote/BAC-L.US.md)
- [BAC-K.US](https://longbridge.com/en/quote/BAC-K.US.md)
- [BML-H.US](https://longbridge.com/en/quote/BML-H.US.md)
- [BAC-N.US](https://longbridge.com/en/quote/BAC-N.US.md)
- [BAC-E.US](https://longbridge.com/en/quote/BAC-E.US.md)
- [MER-K.US](https://longbridge.com/en/quote/MER-K.US.md)
- [BAC-O.US](https://longbridge.com/en/quote/BAC-O.US.md)
- [BML-G.US](https://longbridge.com/en/quote/BML-G.US.md)
- [BAC-M.US](https://longbridge.com/en/quote/BAC-M.US.md)
- [BAC-B.US](https://longbridge.com/en/quote/BAC-B.US.md)
- [BML-J.US](https://longbridge.com/en/quote/BML-J.US.md)
- [BAC-S.US](https://longbridge.com/en/quote/BAC-S.US.md)
- [BAC-P.US](https://longbridge.com/en/quote/BAC-P.US.md)
- [8648.JP](https://longbridge.com/en/quote/8648.JP.md)
- [RVMDW.US](https://longbridge.com/en/quote/RVMDW.US.md)

## Related News & Research

- [TGTX Stock Alert: What to Know as Takeover Rumors Swirl Around TG Therapeutics](https://longbridge.com/en/news/296647082.md)
- [Jefferies Reaffirms Their Buy Rating on TG Therapeutics (TGTX)](https://longbridge.com/en/news/290442333.md)
- [Tredegar (NYSE:TG) Insider Arijit Dasgupta Acquires 2,093 Shares of Stock](https://longbridge.com/en/news/296278499.md)
- [If You Invested $1,000 In Moderna Stock at IPO, Here's How Much You'd Have Now](https://longbridge.com/en/news/296641626.md)
- [MEXC Lists Ondo Tokenized Stock Moderna (MRNAON), Expanding Access to U.S. Biotech Exposure](https://longbridge.com/en/news/296603043.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**